{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T12:08:12Z","timestamp":1657195692862},"reference-count":10,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1157\/13112095","type":"journal-article","created":{"date-parts":[[2007,11,18]],"date-time":"2007-11-18T17:32:45Z","timestamp":1195407165000},"page":"677","source":"Crossref","is-referenced-by-count":1,"title":["Micosis fungoide tratada con bexaroteno. Estudio de 13 casos"],"prefix":"10.1016","volume":"129","author":[{"given":"Elena","family":"Roche Gam\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"P\u00e9rez Ferriols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Vilata Corell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Alegre de Miquel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13112095_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clindermatol.2003.12.003","article-title":"Current management strategies for cutaneous T-cell lymphoma","volume":"22","author":"Knobler","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1157\/13112095_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1157\/13080454","article-title":"Hipotiroidismo secundario a tratamiento con bexaroteno","volume":"125","author":"Sucunza","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13112095_bib3","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results","volume":"19","author":"Duvic","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1157\/13112095_bib4","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma","volume":"137","author":"Duvic","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1157\/13112095_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3816\/CLM.2003.n.006","article-title":"Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma","volume":"3","author":"Sherman","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1157\/13112095_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0001-7310(05)73155-0","article-title":"Tratamiento de linfomas cut\u00e1neos de c\u00e9lulas T con bexaroteno","volume":"96","author":"Lasa","year":"2005","journal-title":"Actas Dermosifiliogr"},{"key":"10.1157\/13112095_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0001-7310(06)73408-1","article-title":"Tratamiento de micosis fungoide con PUVA y bexaroteno","volume":"97","author":"Ortiz-Romero","year":"2006","journal-title":"Actas Dermosifiliogr"},{"key":"10.1157\/13112095_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1575-0922(06)71126-3","article-title":"Alteraciones endocrinometab\u00f3licas inducidas por bexaroteno en el tratamiento del linfoma cut\u00e1neo de c\u00e9lulas T","volume":"53","author":"Marco","year":"2006","journal-title":"Endocrinol Nutr"},{"key":"10.1157\/13112095_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaad.2005.06.044","article-title":"Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with Sezary syndrome","volume":"53","author":"Kreuter","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1157\/13112095_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaad.2006.01.022","article-title":"Bexarotene and systemic disease progression in CTCL?","volume":"55","author":"Dummer","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307729585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307729585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T14:49:19Z","timestamp":1556981359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775307729585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":10,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0025775307729585"],"URL":"https:\/\/doi.org\/10.1157\/13112095","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}